Welltower Analyst Ratings
Wells Fargo: Maintaining the Ventas (VTR.US) rating, adjusted from a wait-and-see shareholding rating to a shareholding wait-and-see rating, and the target price was adjusted from $46.00 to $49.00.
Wells Fargo: Maintaining the Welltower (WELL.US) rating, adjusted from an increase in holdings to an increase rating, and the target price was adjusted from $107.00 to $111.00.
Ventas Analyst Ratings
Wells Fargo Maintains Overweight on Welltower, Raises Price Target to $111
Healthcare Realty Trust Analyst Ratings
National Health Investors Analyst Ratings
CareTrust REIT Analyst Ratings
Wells Fargo Maintains Equal-Weight on CareTrust REIT, Raises Price Target to $26
Wells Fargo Maintains Equal-Weight on Healthcare Realty Trust, Raises Price Target to $16
Wells Fargo Maintains Overweight on National Health Investors, Raises Price Target to $69
Truist Securities: Maintaining the Medical Properties Trust (MPW.US) rating, adjusted from holding to holding rating, and adjusted target price from $4.50 to $5.00.
Medical Properties Trust Analyst Ratings
Wells Fargo Keeps Their Buy Rating on Welltower (WELL)
Wells Fargo Reaffirms Their Buy Rating on National Health Investors (NHI)
Wells Fargo Keeps Their Hold Rating on CareTrust REIT (CTRE)
Ventas Inc: Wells Fargo raises price target from $46 to $49
Welltower Inc: Wells Fargo raises price target from $107 to $111
Healthcare Realty Trust Inc: Wells Fargo Raises Price Target From $15 To $16
CareTrust REIT Inc: Wells Fargo Raises Price Target from $24 to $26